Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / NUCB2/Nesfatin-1 Regulation of Chronic Visceral Hyperalgesia.

< BACK TO ARCHIVE


2022


Appl Bionics Biomech


http://www.ncbi.nlm.nih.gov/pubmed/35847627?dopt=Abstract


2022

NUCB2/Nesfatin-1 Regulation of Chronic Visceral Hyperalgesia.

Authors

NUCB2/Nesfatin-1 Regulation of Chronic Visceral Hyperalgesia.
Gu Q, Lei Y, Wu J, He T, Li J, Song S
Appl Bionics Biomech. 2022; 2022:4079533.
PMID: 35847627.

Abstract

We previously described that different concentration Nucleobindin-2 (NUCB2)/Nesfatin-1 gradients differently regulated visceral hypersensitivity in irritable bowel syndrome. Therefore, this study is aimed at evaluating the effect of NUCB2/Nesfatin-1 on model rats with chronic visceral hyperalgesia.
Read This Paper